Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus

Hormone and Metabolic Research

Volumn 29, Issue 4, 1997, Pages 180-183

  Martina, V ^a   Bruno, G ^a   Tagliabue, M ^a   Maccario, M ^a   Bertaina, S ^a   Zumpano, E ^a   Arvat, E ^a   Ghigo, E ^a   Camanni, F ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Growth Hormone; Growth Hormone Releasing Hormone; Insulin Dependent Diabetes Mellitus

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PYRIDOSTIGMINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOMATOSTATIN RELEASE;

EID: 0030903795     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979017     Document Type: Article

References (24)

1. Asplin C, Faria A, Carlsen E, Vaccaro V, Barr R, Iranmanesh A, Lee M, Veldhuis J, Evans W: Alterations in the pulsation mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69: 239 - 245 (1989).
2. Johansen K, Hansen AP: High 24-hour levels of serum growth hormone in juvenile diabetics. Brit Med J 2: 356 - 357 (1969).
3. Hansen AP: Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest 49: 1467 - 1478 (1970).
4. Krassowski J, Felber JP, Rogala H, Jeske W, Zgliczynski S: Exaggerated growth hormone response to growth hormone releasing hormone in type 1 diabetes mellitus. Acta Endocrinol 117: 225 - 229 (1988).
5. Speroni G, Ceda GP, Capretti L, Valenti G: Clonidine and GH secretion in insulin dependent diabetes. Horm Metab Res 15: 46 - 47 (1983).
6. Caviezel F, Lepore G, Maglio ML, Croci M, Comi G, Morricone L: Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus. Acta Diabetol Lat 26: 133 - 145 (1989).
7. Dasmahapatra A, Urdanivia E, Cohen MP: Growth hormone response to thyrotropin-releasing hormone in diabetics. J Clin Endocrinol Metab 52: 859 - 862 (1981).
8. Giampietro O, Miccoli R, Ferdeghini M, Penno G, Masoni A, Navalesi R: Inappropriate growth hormone response to luteinizing hormone-releasing hormone in diabetes mellitus. Metabolism 36: 1149 - 1153 (1987).
9. Lorenzi M, Karam J, Mcllroy M: Increased growth hormone response to dopamine infusion in insulin dependent diabetic subjects: indication of possible blood brain barrier abnormality. J Clin Invest 65: 146 - 153 (1980).
10. Giustina A, Bossoni S, Cimino A, Pizzocolo G, Romanelli G, Weheremberg WB: Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone stimulated GH secretion. J Clin Endocrinol Metab 71: 1486 - 1490 (1990).
11. Pietschmann P, Schernthaner G, Stephenson J, Lang I, Templ H: Enhanced growth hormone responses to growth hormone releasing hormone in male type 1 diabetic patients. Horm Metab Res 23: 379 - 382 (1991).
12. Schaper NC, Tamsma JT, Sluiter WJ, Roelse H, Doorenbos H: Growth hormone autoregulation in type I diabetes mellitus. Acta Endocrinol 122: 32 - 39 (1990).
13. Burday SZ, Fine PH, Schalch DS: Growth hormone secretion in response to arginine infusion in normal and diabetic subjects: relationship to blood glucose levels. J Lab Clin Med 71: 897 - 891 (1968).
14. Hansen AP: The effect of intravenous glucose infusion on the exercise-induced serum growth hormone rise in normals and juvenile diabetics. Scand J Clin Lab Invest 28: 195 - 205 (1971).
15. Mims RB, Scott CL, Modebe OM, Berthune JE: Prevention of Ldopa-induced growth hormone stimulation by hyperglycemia. J Clin Endocrinol Metab 37: 660 - 663 (1973).
16. Press M, Tamborlane WV, Thorner MO, Vale V, Rivier J, Gertner JM, Sherwin RS: Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose mediate suppression. Diabetes 310: 804 - 806 (1984).
17. Sharp PS, Foley K, Kohner EM: Evidence for a central abnormality in the regulation of growth hormone secretion in insulin-dependent diabetes. Diabetes Med 1: 205 - 208 (1984).
18. Ghigo E, Miola C, Aimaretti G, Valente F, Procopio M, Arvat E, Yin-Zhang W, Camanni F: Arginine abolishes the inhibitory effect of glucose on growth hormone response to growth hormone-releasing hormone in man. Metabolism 41: 1000 -1003 (1992).
19. Penalva A, Bruguera B, Casabiell X, Tresguerres JAF, Dieguez C, Casanueva FF: Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycaemia on GHRH-induced GH secretion in man. Does acute hyperglycaemia act through hypothalamic release of somatostatin? Neuroendocrinology 49: 551 - 554 (1989).
20. Locatelli V, Torsello A, Redaelli M, Ghigo E, Massara F, Muller EE: Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone releasing hormone in the rat: evidence for mediation by somatostatin. J Endocrinol 111: 271 - 278 (1986).
21. Massara F, Ghigo E, Molinatti P, Mazza E, Locatelli V, Camanni F: Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol 113: 12 - 16 (1986).
22. Ross RJM, Borgess F, Grossmann A, Smith R, Ngahfoong L, Rees LH, Savage MO, Besser GM: Growth hormone treatment in man blocks the response to growth hormone releasing hormone; evidence for a direct effect of growth hormone. Clin Endocrinol 26: 117 - 123 (1987).
23. Baumann G: Growth hormone binding protein and growth hormone sensitivity. Endocrinol Metab 1 (Suppl A): 21 - 25 (1994).
24. Dieguez C, Page MD, Scanlon MF: Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol 28: 109 - 143 (1988).